Search Results

The acquisition expands scalable trial operations across real-world care settings

• New research based on directly measured metrics of patients in a randomized, placebo-controlled clinical trial provides a mechanistic explanation for the clinical benefit provided by the antimicrobial agent clarithromycin in patients with community-acquired pneumonia (CAP). • Insights argue for effects of clarithromycin on immune function and inflammation in addition to its acknowledged antimicrobial action

At some point in your research career, you may find yourself transitioning from academia to industry or vice versa. To best set yourself up for success, adapt your approach to the specific scientific culture where you work.

In August last year, the Health Department cut around $500 million in mRNA research funding, with Health Secretary Robert F. Kennedy Jr. saying the agency would instead divert the money “toward safer, broader vaccine platforms.”

As clinical research evolves, disruptive trial designs are reshaping how oncology advances. By integrating novel methodologies, strategic innovation, and patient-centered approaches, MEDSIR is driving a new era in cancer research, one that accelerates development, enhances efficiency, and delivers more meaningful therapeutic progress for patients worldwide.